Livingston HealthCare is pleased to announce that Deb Anczak has been named
as Chief Executive Officer. Anczak has served as Interim CEO at LHC since
January 2018.
Anczak came to LHC in 2011 as pharmacy manager. In 2014, she took on the
role of Director of Performance Improvement and held both of these positions
until taking over as Interim CEO.
“We couldn’t be more pleased to have found such an exceptional
match for this position internally,” said Denis Prager, Chair of
the LHC Board of Directors. “Deb brings new ideas and fresh perspective
to the organization, combined with first-hand knowledge of its day-today
operations. She will continue Livingston HealthCare’s forward momentum
and help propel us to the next level.”
“I am honored to step into the role of CEO at Livingston HealthCare,”
said Anczak. “Our team here is outstanding and I am excited to work
together to achieve the goals outlined in our strategic plan. Providing
exceptional, patient-centered care for our community will remain at the
center of all we do.”
Anczak received a Bachelor of Science degree in pharmacy from the University
of Wisconsin-Madison and a master’s degree in health services administration
from University of St. Francis in Joliet, Illinois.